← Open Payments lookup

RACHEL EASTERS: Open Payments

NPI 1447640628 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,296 in 250 payments from 50 companies in 2025. Trend: 2023 $3,610 · 2024 $3,614 · 2025 $5,296

Food & beverage: $5,161Education: $166
CompanyPaymentsAmount
Janssen Biotech, Inc.22$551
Novartis Pharmaceuticals Corporation24$494
Takeda Pharmaceuticals U.S.A., Inc.14$332
PFIZER INC.15$324
Celgene Corporation17$320
Incyte Corporation10$273
AstraZeneca Pharmaceuticals LP11$225
GlaxoSmithKline, LLC.12$199
SERVIER PHARMACEUTICALS LLC9$171
Eisai Inc.8$141

Products named: REBLOZYL, RYBREVANT, FRUZAQLA, IMFINZI, LUTATHERA, Lenvima, KISQALI, TALVEY.

Industry payments across AL — which companies pay providers there.